SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027601
Filing Date
2021-05-13
Accepted
2021-05-13 16:31:59
Documents
50
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 Q1'21 - 10-Q rlay-10q_20210331.htm 10-Q 1858476
2 EX-10.2 rlay-ex102_187.htm EX-10.2 25587
3 EX-10.4 rlay-ex104_188.htm EX-10.4 18280
4 EX-31.1 rlay-ex311_6.htm EX-31.1 18254
5 EX-31.2 rlay-ex312_7.htm EX-31.2 18129
6 EX-32.1 rlay-ex321_8.htm EX-32.1 13287
  Complete submission text file 0001564590-21-027601.txt   5089622

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rlay-20210331.xml EX-101.INS 924291
8 XBRL TAXONOMY EXTENSION SCHEMA rlay-20210331.xsd EX-101.SCH 36454
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rlay-20210331_cal.xml EX-101.CAL 34557
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rlay-20210331_def.xml EX-101.DEF 104821
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20210331_lab.xml EX-101.LAB 283390
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20210331_pre.xml EX-101.PRE 197658
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 21920145
SIC: 2836 Biological Products, (No Diagnostic Substances)